MCM
Moore Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4M | Buy |
+150,000
| New | +$12.4M | 0.16% | 92 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 557 |
|
|
2024
Q4 | – | Sell |
-252,500
| Closed | -$24.9M | – | 545 |
|
|
2024
Q3 | $24.9M | Buy |
252,500
+47,500
| +23% | +$4.69M | 0.46% | 33 |
|
|
2024
Q2 | $19M | Sell |
205,000
-15,000
| -7% | -$1.39M | 0.33% | 76 |
|
|
2024
Q1 | $20.9M | Sell |
220,000
-1,570,000
| -88% | -$149M | 0.33% | 56 |
|
|
2023
Q4 | $160M | Buy |
1,790,000
+1,740,000
| +3,480% | +$155M | 2.75% | 4 |
|
|
2023
Q3 | $3.65M | Buy |
+50,000
| New | +$3.65M | 0.07% | 157 |
|
|
2023
Q2 | – | Sell |
-280,000
| Closed | -$21.3M | – | 572 |
|
|
2023
Q1 | $21.3M | Sell |
280,000
-2,902,662
| -91% | -$221M | 0.45% | 35 |
|
|
2022
Q4 | $264M | Buy |
+3,182,662
| New | +$264M | 6.27% | 2 |
|
|
2022
Q2 | – | Sell |
-86,035
| Closed | -$7.73M | – | 792 |
|
|
2022
Q1 | $7.73M | Sell |
86,035
-1,249,565
| -94% | -$112M | 0.2% | 99 |
|
|
2021
Q4 | $150M | Buy |
+1,335,600
| New | +$150M | 2.97% | 1 |
|
|
2020
Q2 | – | Sell |
-225,000
| Closed | -$17.4M | – | 294 |
|
|
2020
Q1 | $17.4M | Buy |
+225,000
| New | +$17.4M | 0.72% | 32 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 373 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 323 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 293 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 322 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 309 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 294 |
|
|
2017
Q2 | – | Sell |
-300,000
| Closed | -$20.8M | – | 229 |
|
|
2017
Q1 | $20.8M | Buy |
300,000
+245,000
| +445% | +$17M | 0.56% | 32 |
|
|
2016
Q4 | $3.26M | Buy |
+55,000
| New | +$3.26M | 0.11% | 102 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 300 |
|